Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR® (temozolomide) capsules, for oral use TEMODAR® (temozolomide) for injection, for intravenous use Initial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
TEMODAR is indicated for the treatment of adults with newly diagnosed glioblastoma, concomitantly with radiotherapy and then as maintenance treatment. TEMODAR is indicated for the: adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma; treatment of adults with refractory anaplastic astrocytoma.
- generic_name
- temozolomide
- product_names
- Temozolomide
- ndc
- 0085-3004, 0085-3004-05, 0085-3004-03, 0085-3004-04, 0085-1519, 0085-1519-05, 0085-1519-03, 0085-1519-04, 0085-1366, 0085-1366-05, 0085-1366-03, 0085-1366-04, 0085-1425, 0085-1425-05, 0085-1425-03, 0085-1425-04, 0085-1430, 0085-1430-05, 0085-1430-03, 0085-1430-04, 0085-1417, 0085-1417-03, 0085-1417-02, 0085-1381, 0085-1381-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en